Bevacizumab for choroidal neovascularization secondary to pathologic myopia: Is there a decline of the treatment efficacy after 2 years? - Concepedia

Concepedia

Publication | Closed Access

Bevacizumab for choroidal neovascularization secondary to pathologic myopia: Is there a decline of the treatment efficacy after 2 years?

39

Citations

34

References

2010

Year

Bogomil Voykov, Faik Gelişken, W. Inhoffen, Michael Voelker, Karl Ulrich Bartz‐Schmidt, Focke Ziemssen

Graefe s Archive for Clinical and Experimental Ophthalmology

Ocular DiseaseVitreous BodyOphthalmologyTreatment EfficacyChoroidal NeovascularizationOcular PathologyMedicine

References

	Year	Citations

Page 1